Forest Labs (FRX) Wins FDA Approval for COPD Treatment -Bloomberg
Tweet Send to a FriendGet Alerts FRX Hot Sheet
Down)
Trade FRX Now!
Bloomberg reporting Forest Labs (NYSE: FRX) has won approval for its COPD treatment.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Liberty Global (LBTYA) Interested in Kabel Deutschland - FT
- A Sale or an IPO for Nokia Siemens Networks? (NOK)
- Columbia Pacific Raises Stake Vitesse Semiconductor (VTSS), Discusses Refinancing/Sale
Create E-mail Alert Related Categories
Rumors
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
